about
Immune response, safety, and survival and quality of life outcomes for advanced colorectal cancer patients treated with dendritic cell vaccine and cytokine-induced killer cell therapyTreatment of early gastric cancer in the Western World.Cardiovascular toxicity associated with adjuvant trastuzumab therapy: prevalence, patient characteristics, and risk factors.Current status of predictive biomarkers for neoadjuvant therapy in esophageal cancerThe role of immunotherapy in solid tumors: report from the Campania Society of Oncology Immunotherapy (SCITO) meeting, Naples 2014Feasibility study of DCs/CIKs combined with thoracic radiotherapy for patients with locally advanced or metastatic non-small-cell lung cancerThe role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression.Clinical studies applying cytokine-induced killer cells for the treatment of gastrointestinal tumors.Constitutive activation of oncogenic PDGFRα-mutant proteins occurring in GIST patients induces receptor mislocalisation and alters PDGFRα signalling characteristics.Promising role for Gc-MAF in cancer immunotherapy: from bench to bedside.Immunotherapy in Gastrointestinal Cancers.Immunotherapy in Melanoma, Gastrointestinal (GI), and Pulmonary MalignanciesChemotherapy combined with dendritic cell vaccine and cytokine-induced killer cells in the treatment of colorectal carcinoma: a meta-analysis
P2860
Q21284687-6DA970A9-9666-4DE4-A024-5C3199F06D6FQ33626791-ECB63EC8-34FA-49C5-823F-0439E0B684DCQ33949465-F1A70766-709C-456D-B663-589427C7FE47Q34048027-42FC095D-9B8B-4DC2-A45C-DFEAA005487DQ34402325-B1925E9C-1BBA-48B2-B9AD-8756705ACC7EQ36820371-44513C20-A9B2-40AA-B6E5-E10B30789AB6Q36946662-9AFE6EDF-A826-4029-B20B-2844FB6A63E2Q37704879-E10DE783-E094-49D3-9D43-4492C7C2DAD2Q38886353-96EC4F2C-4E64-49F8-B412-421C3B653A6AQ47104354-5B27DFA2-C55E-4BDC-A2DF-FA12867F4A88Q53183990-0EBF2AF2-FF03-499E-AE91-71243370DAAFQ56896166-12A69798-DB86-4364-B093-F5B12BCB5F94Q59125672-0E3D6883-1729-4F9B-8CDC-1C4E21C180B6
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Immunotherapy for gastrointestinal malignancies.
@ast
Immunotherapy for gastrointestinal malignancies.
@en
type
label
Immunotherapy for gastrointestinal malignancies.
@ast
Immunotherapy for gastrointestinal malignancies.
@en
prefLabel
Immunotherapy for gastrointestinal malignancies.
@ast
Immunotherapy for gastrointestinal malignancies.
@en
P2093
P2860
P1433
P1476
Immunotherapy for gastrointestinal malignancies.
@en
P2093
Amod A Sarnaik
Nasreen A Vohra
Paul G Toomey
Shari A Pilon-Thomas
Tomar Ghansah
P2860
P356
10.1177/107327481302000106
P577
2013-01-01T00:00:00Z